TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T04820	Plasmodium CDK Pfmrk	D03KKR	Fasudil	Phase 3	3547	C14H17N3O2S	291.37	C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	D05ADP	R-roscovitine	Phase 2	160355	C19H26N6O	354.4	CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3	IC50 > 1000000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	D00BPA	Olomoucine	Terminated	4592	C15H18N6O	298.34	CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3	IC50 > 1000000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	B2UTS8	N-(4-Aminobutyl)naphthalene-1-sulfonamide	Investigative	5679	C14H18N2O2S	278.37	C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)NCCCCN	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	B5RL6K	1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-	Investigative	4216	C15H17IN2O2S	416.3	C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3I	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	B6S8ZK	2-Hydroxy-5,6-dihydrobenzofuro[3,2-c]quinoline-6-one	Investigative	44329248	C15H9NO3	251.24	C1=CC=C2C(=C1)C3=C(O2)C4=C(C=CC(=C4)O)NC3=O	IC50 = 539000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	B92NAS	N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide	Investigative	5681	C16H21ClN2O2S	340.9	C1=CC2=C(C=CC=C2Cl)C(=C1)S(=O)(=O)NCCCCCCN	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BB3J7C	N-(4-Aminobutyl)-5-chloronaphthalene-1-sulfonamide	Investigative	5680	C14H17ClN2O2S	312.8	C1=CC2=C(C=CC=C2Cl)C(=C1)S(=O)(=O)NCCCCN	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BC8F9Q	5-{[(2S)-2-Methylpiperazin-1-yl]sulfonyl}isoquinoline	Investigative	449240	C14H17N3O2S	291.37	C[C@H]1CNCCN1S(=O)(=O)C2=CC=CC3=C2C=CN=C3	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BE1MT5	2,5-Dichloro-N-(3,5-dichlorophenyl)thiophene-3-sulfonamide	Investigative	49798509	C10H5Cl4NO2S2	377.1	C1=C(C=C(C=C1Cl)Cl)NS(=O)(=O)C2=C(SC(=C2)Cl)Cl	IC50 = 332800 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BGWQ47	3',4-Dinitrochalcone	Investigative	5378133	C15H10N2O5	298.25	C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)/C=C/C2=CC=C(C=C2)[N+](=O)[O-]	IC50 = 268000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BMD25K	N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide	Investigative	3546	C12H15N5O2S	293.35	C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCN=C(N)N	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BQMZ02	(2E)-1,3-Bis(3-nitrophenyl)-2-buten-1-one	Investigative	5463500	C16H12N2O5	312.28	C/C(=C\\C(=O)C1=CC(=CC=C1)[N+](=O)[O-])/C2=CC(=CC=C2)[N+](=O)[O-]	IC50 > 256000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	BVP37L	1-(5-Isoquinolinesulfonyl)piperazine	Investigative	3545	C13H15N3O2S	277.34	C1CN(CCN1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	D01SLS	ML9	Investigative	4217	C15H17ClN2O2S	324.8	C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl	IC50 > 500000 nM	Non binder
T04820	Plasmodium CDK Pfmrk	D09FFE	H-89	Investigative	449241	C20H20BrN3O2S	446.4	C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNC/C=C/C3=CC=C(C=C3)Br	IC50 > 500000 nM	Non binder